Articles from Regenerative Medical Technology Group

RMTG Launches ISSCA AI(TM) Clinical Intelligence Platform, Extending Its Global Regenerative Medicine Network Into AI-Driven Clinical Infrastructure
New AI Platform Builds on a 30+ Country Physician Network and the ISSCA Mobile App to Create a Connected, Technology-Enabled Ecosystem for Regenerative and Longevity Medicine
Global Stem Cells Group (OTC:RMTG) Launches ISSCA Mobile App, Advancing Its Buildout of a Global Digital Ecosystem for Regenerative Medicine
New physician-facing platform digitizes a 30+ country network and lays the foundation for ISSCA AI™, positioning RMTG at the intersection of regenerative medicine and scalable health technology
Articles from Regenerative Medical Technology Group | MarketMinute